GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,386,000 | – | 11,000 | – | 2.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $21,655,000 | 13.09% |
| Lamond Capital Partners LLC | 120,000 | $10,964,000 | 5.47% |
| GREAT POINT PARTNERS LLC | 100,000 | $6,944,000 | 2.91% |
| Perceptive Advisors | 400,000 | $27,776,000 | 2.06% |
| Iguana Healthcare Management, LLC | 60,687 | $4,214,000 | 1.39% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 46,000 | $3,195,000 | 0.92% |
| FT Options LLC | 51,300 | $1,191,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 310,122 | $21,535,000 | 0.87% |
| Folger Hill Asset Management LP | 176,033 | $12,224,000 | 0.74% |
| CLOUGH CAPITAL PARTNERS L P | 220,276 | $15,296,000 | 0.72% |